Organigram Stock Bounces Off Lows; Margins in Focus Next
Organigram’s Nasdaq shares closed Friday at $1.12, down 0.9% but up 4.7% from May 15, while its TSX shares ended at C$1.56. The company reported a C$0.9 million net loss for the quarter, with revenue down 9% to C$59.8 million. U.S. and Canadian exchanges are split by holidays, with Nasdaq closed Monday for Memorial Day. Organigram raised its 2026 revenue forecast above C$350 million after acquiring Sanity Group.
